NL-OMON42466
Completed
Not Applicable
A phase I study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of multiple-dose subcutaneous and intravenous administration of OMS721 in healthy subjects - OMS721 MD SC and IV dose in HV
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- autoimmune diseases
- Sponsor
- Omeros Corporation
- Enrollment
- 24
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •healthy volunteers
- •18\-54 years, inclusive
- •BMI: 19\.0\-32\.0 kg/m2, inclusive
Exclusion Criteria
- •Suffering from hepatitis B, hepatitis C, cancer or HIV/AIDS. In case of participation in another drug study within 60 days before the start of this study or being a blood donor within 60 days from the start of the study. In case of donating more than 0\.5 liters of blood in the 60 days prior the start of this study.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 1
Inhalation of Leukotriene B4 (LTB4) in patients suffering from BronchiectasisACTRN12614001199606TB4 Sweden AB30
Completed
Phase 1
Phase I trial to evaluate the safety and tolerability of GDC-0214 in healthy volunteers and patients with mild asthmaAsthmaRespiratory - AsthmaACTRN12617001227381Genentech, Inc.102
Completed
Phase 1
Phase I trial to evaluate the safety and tolerability of GDC-4379 in healthy volunteers and patients with mild asthmaAsthmaRespiratory - AsthmaACTRN12619000227190Genentech128
Completed
Not Applicable
A phase 1 study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of OMS1029 with single-dose intravenous and subcutaneous administration in healthy subjectsNL-OMON53550Omeros Corporation48
Completed
Not Applicable
GEN-001 single dose phase 1 studyNot ApplicableKCT0005339Chonbuk National University Hospital20